Description
HIV and Aging: Clinical Updates The successes of ART and sustained viral-suppression mean that long-term care strategies for persons with HIV are coming into focus. Consequently, there will need to be increased attention to the co-incidence of HIV, long-term drug therapy and the co-morbidities and chronic health concerns commonly associated with the aging population at large. In 2018, over half (51%) of people in the United States (US) and dependent areas with diagnosed HIV were aged 50 and older. Though new HIV diagnoses are declining among people over the age of 50, about one in six HIV diagnoses in 2018 were among this age group.Addressing Challenges in the Care of Older Persons with HIV Educational Objectives After completing this activity, the participant should be better able to:
|
Contributors
-
Michelle Iandiorio, MD
University of New Mexico Health Science Center Clinical Director, SCAETC Medical Director, ECHO Institute Albuquerque, New Mexico
-
Jonathan Appelbaum, MD, FACP, AAHIVS
Laurie L. Dozier Jr., MD, Professor of Internal Medicine Florida State University, College of Medicine Florida State University, College of Medicine Tallahassee, Florida